(click on link to learn more)
|Dermatomyositis (DM)||IgPro20_3007||A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of IgPro20 in Adults with Dermatomyositis (DM) [RECLAIIM]||Recruiting|
|Pediatric CIDP||IgPro10_4002||Randomized Study of Single vs. Multiple Privigen Dose Regimens in Pediatric CIDP||Recruiting|
|Hereditary Angioedema (HAE)||CSL312_3002||Long-term Safety and Efficacy of CSL312 (Garadacimab) in the Prophylactic Treatment of Hereditary Angioedema Attacks||Active, Not Recruiting|
|Hidradenitis Suppurativa and Palmoplantar Pustulosis||CSL324_1002||A Study of the Safety and Pharmacokinetics of Repeat Doses of CSL324 in Subjects with Hidradenitis Suppurativa and Palmoplantar Pustulosis||Active, Not Recruiting|
|Inflammatory Neuropathy||pHeNIx||Hizentra® in Inflammatory Neuropathies - pHeNIx Study||Recruiting|
|Healthy Subjects||CSL312_1004||A Study to Assess the Relative Bioavailability of CSL312 Administered Subcutaneously via a Prefilled Syringe Assembled to an Autoinjector Compared to a Prefilled Syringe Assembled to a Needle Safety Device in Healthy, Adult Subjects.||Recruiting|
|Healthy Subjects||CSL730_1002||A Phase 1 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Subcutaneous CSL730 in Healthy Adult Subjects||Recruiting|
Current Clinical Trials
A clinical trial is a research study that is done to find out if medical treatments can improve people’s health. A medical treatment can be a drug, medical device, medical procedure, or a change in a person’s behavior such as diet or exercise. People who take part in clinical trials are volunteers. They are also called “participants.” Clinical Trials FAQs.
Want to Participate In a Clinical Trial?
There are a lot of important things to think about before deciding to participate. Check out some of the key considerations here.